We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 306 results
  1. The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration

    Background

    Tumor-associated macrophages (TAMs) are associated with unfavorable patient prognosis in many cancer types. However, TAMs are a...

    Umair Majid, Christian Holst Bergsland, ... Ragnhild A. Lothe in Cellular Oncology
    Article Open access 26 February 2024
  2. Ancient ubiquitous protein 1 (AUP1) is a prognostic biomarker connected with TP53 mutation and the inflamed microenvironments in glioma

    Introduction

    Glioblastoma (GBM) is the most common and lethal brain tumor. The current treatment is surgical removal combined with radiotherapy and...

    Pei-Chi Chang, Yu-Chieh Lin, ... Yao-Feng Li in Cancer Cell International
    Article Open access 07 April 2023
  3. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection

    Background

    Immunoscore have shown a promising prognostic value in many cancers. We aimed to establish and validate an immune classifier to predict...

    Wei-Ren Liu, Meng-**n Tian, ... Ying-Hong Shi in British Journal of Cancer
    Article Open access 07 May 2020
  4. Interplay between WNT/PI3K-mTOR axis and the microbiota in APC-driven colorectal carcinogenesis: data from a pilot study and possible implications for CRC prevention

    Background

    Wnt/β-catenin signalling impairment accounts for 85% of colorectal cancers (CRCs), including sporadic and familial adenomatous polyposis...

    Floriana Jessica Di Paola, Chiara Alquati, ... Luigi Ricciardiello in Journal of Translational Medicine
    Article Open access 05 July 2024
  5. Tumor-infiltrating Lymphocytes as Markers of the Antitumor Therapy Efficacy: Myth or Reality?

    Tumor-infiltrating lymphocytes (TIL) are an important prognostic factor of the antitumor therapy effectiveness and the course of the malignant...
    Mikhail V. Kiselevskiy, Tatiana N. Zabotina, ... Irina Zh. Shubina in Cancer Treatment: An Interdisciplinary Approach
    Chapter 2023
  6. The role of biomarkers in personalized immunotherapy

    Background

    Immune checkpoint inhibitors have revolutionized cancer therapeutic paradigm and substantially improved the survival of patients with...

    Kamya Sankar, **g Christine Ye, ... Siwen Hu-Lieskovan in Biomarker Research
    Article Open access 18 May 2022
  7. In CAR T cell-treated lymphomas, the T cell rich get richer

    Theodora Anagnostou, Joshua D. Brody in Nature Medicine
    Article 29 August 2022
  8. Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

    Over the past decade, immunotherapy has become an increasingly fundamental modality in the treatment of cancer. The positive impact of immune...

    Paolo A. Ascierto, Antonio Avallone, ... Igor Puzanov in Journal of Translational Medicine
    Article Open access 07 June 2022
  9. Impact of preoperative white blood cell count on outcomes in different stage colorectal cancer patients undergoing surgical resection: a single-institution retrospective cohort study

    Purpose

    To explore the association between preoperative WBC count and the long-term survival outcomes and clinical outcomes in different stage...

    Bei Wang, Dandan Ling, ... Jianghui Xu in BMC Cancer
    Article Open access 21 February 2024
  10. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages

    Background

    Tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) may be useful prognostic indicators in endometrial cancer....

    Takako Kono-Sato, Kosuke Miyai, ... Hitoshi Tsuda in BMC Cancer
    Article Open access 02 April 2022
  11. Cancer Immunotherapy Clinical Trials

    Immunotherapy is a relatively new method of treatment used in oncology. Cancer immunotherapy, also known as immuno-oncology (IO), is a form of cancer...
    Living reference work entry 2022
  12. Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer

    Background

    Although high T cell density is a strong favourable prognostic factor in colorectal cancer, the significance of the spatial distribution of...

    Hanna Elomaa, Maarit Ahtiainen, ... Juha P. Väyrynen in British Journal of Cancer
    Article Open access 21 April 2022
  13. The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer

    Tumour immunotherapy has achieved remarkable clinical success in many different types of cancer in the past two decades. The outcome of immune...

    Yanbin Liu, Zhenjiang Liu, ... Yarong Liu in British Journal of Cancer
    Article 14 July 2023
  14. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer – possible implications for immunotherapy

    Background

    The immune response has important clinical value in colorectal cancer (CRC) in both prognosis and response to immunotherapy. This study...

    Sofia Edin, Björn Gylling, ... Richard Palmqvist in British Journal of Cancer
    Article Open access 01 December 2023
  15. The Hurdle of Precision Medicine in Cancer Immunotherapy: Personalization Now or Then?

    Moving away from the generic treatment for all cancer, precision medicine provides a targeted therapy based on the different profile presented. Since...
    Joseph Jun Quan Ng, Denise Goh, ... Joe Poh Sheng Yeong in Handbook of Cancer and Immunology
    Living reference work entry 2023
  16. The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review

    Colorectal cancer represents the second leading cause of cancer-related death worldwide. The therapeutic field of immuno-oncology has rapidly gained...

    Alexandra M. Zaborowski, Des C. Winter, Lydia Lynch in British Journal of Cancer
    Article Open access 23 July 2021
  17. Introduction on Cancer Immunodiagnosis

    With the increasing burden of cancer, there is a growing need for efficient diagnostic, prognostic and prediction tools to facilitate patient...
    Raha Zamani, Nima Rezaei in Handbook of Cancer and Immunology
    Living reference work entry 2023
  18. A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas

    Meningiomas are the most common intracranial brain tumours. These tumours are heterogeneous and encompass a wide spectrum of clinical aggressivity....

    Laurien L. van de Weijer, Emanuela Ercolano, ... C. Oliver Hanemann in Acta Neuropathologica Communications
    Article Open access 15 December 2023
  19. Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis

    Background

    Molecular differences in colorectal cancer (CRC) are associated with the metastatic route. Patient survival is mainly driven by metastatic...

    Sven Jacob, Florian Bösch, ... Jens Neumann in BMC Cancer
    Article Open access 18 November 2021
  20. Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer

    Background

    Energy metabolism disorder, especially lipid metabolism disorder, is an important biological characteristic of colon cancer. This research...

    Yaobin Lin, Yu **ao, ... Junxin Wu in BMC Medical Genomics
    Article Open access 21 October 2022
Did you find what you were looking for? Share feedback.